- Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide CNBC
- Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market Yahoo Finance
- Amgen obesity drug MariTide: four key questions going forward - STAT STAT
- Novo Nordisk's Ozempic Stock Rally Is Hitting a Wall The Wall Street Journal
- Novo Slides as Amgen Fuels Obesity Drug Competition Fears Bloomberg
Okumaya devam et...